Gland Pharma: Block Deal Buzz and Stock Performance

is back in focus after reports that its promoter, Fosun Pharma Industrial, is likely to sell a 5% equity stake through a block deal. According to CNBC-TV18, citing sources, the proposed deal could be worth around ₹2,279.5 crore, with a floor price of ₹2,763 per share. Interestingly, the stock showed resilience. Gland Pharma closed at ₹2,932.40 on Friday, September 4, gaining 0.84%, despite the stake-sale news. Recent momentum: 1-week: +0.69% 1-month: +12.57% CY2026 YTD: ~70% gain With a market cap of around ₹47,586 crore, Gland Pharma operates in complex injectables, oncology, ophthalmics and other specialized therapies. At ₹2,932, the stock trades at around 42x PE, versus sector PE of 63x. Disclaimer: Investments in securities are subject to market risk. This is for informational purposes only. Investors must verify information before investing and consider their financial position & risk profile.